Illustration: Gabriella Turrisi/Axios
Medical device startup ShiraTronics raised a $66 million Series B to fund its pivotal trial for its migraine neurostimulation product.
Why it matters: Migraines impact 1 out of every 6 Americans, but few health tech interventions besides home-delivered medication are available.
